Heart-lung interaction via infection.
Lung and cardiovascular disease are increasingly recognized to occur in the same patient populations. Infections, either through stimulation of inflammation or through direct infection, can lead to end-organ damage and have been postulated as a potential link between lung and cardiovascular diseases. Mechanisms by which infections may link lung and cardiac diseases include effects of systemic infections, microbial translocation of pathogens from the gastrointestinal tract or other sites, damaging effects of metabolic products, or influences of smoking on the microbiome. Other mechanisms, such as alterations in the local microbiome, environmental exposures, or immune regulation by microbial communities, may be important. These relationships are likely quite complex, with multiple routes between infection and disease possible. A better understanding of the links of infection to lung and heart disease can improve our understanding of the pathogenesis of these disorders and uncover novel therapeutic approaches.
1 Departments of Medicine and Immunology, University of Pittsburgh, Pittsburgh, Pennsylvania.
Alison
A
Morris
D018988:Bacterial Translocation; D002318:Cardiovascular Diseases / Q000276:immunology* / Q000382:microbiology; D041981:Gastrointestinal Tract / Q000382:microbiology*; D015658:HIV Infections / Q000276:immunology*; D006801:Humans; D007249:Inflammation / Q000276:immunology; D008171:Lung Diseases / Q000276:immunology / Q000382:microbiology; D055442:Metabolome; D064307:Microbiota / Q000276:immunology*; D029424:Pulmonary Disease, Chronic Obstructive / Q000276:immunology* / Q000382:microbiology; D012907:Smoking / Q000276:immunology